awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q51581664-892DF9C7-7607-4907-86FE-9881D384EA85
Q51581664-892DF9C7-7607-4907-86FE-9881D384EA85
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51581664-892DF9C7-7607-4907-86FE-9881D384EA85
Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors.
P2860
Q51581664-892DF9C7-7607-4907-86FE-9881D384EA85
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51581664-892DF9C7-7607-4907-86FE-9881D384EA85
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
26dc88fc50674fd3a9cf8c01988e86f2e6007221
P2860
A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer.